SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-077365
Filing Date
2014-02-28
Accepted
2014-02-28 16:16:41
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d652543d10k.htm 10-K 1309504
2 EX-3.3 d652543dex33.htm EX-3.3 77360
3 EX-10.33 d652543dex1033.htm EX-10.33 199828
4 EX-23.1 d652543dex231.htm EX-23.1 2121
5 EX-31.1 d652543dex311.htm EX-31.1 8659
6 EX-31.2 d652543dex312.htm EX-31.2 8823
7 EX-32.1 d652543dex321.htm EX-32.1 5805
14 GRAPHIC g652543g63u87.jpg GRAPHIC 53539
  Complete submission text file 0001193125-14-077365.txt   9714294

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cadx-20131231.xml EX-101.INS 1278220
9 XBRL TAXONOMY EXTENSION SCHEMA cadx-20131231.xsd EX-101.SCH 73320
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cadx-20131231_cal.xml EX-101.CAL 95011
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cadx-20131231_def.xml EX-101.DEF 474983
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cadx-20131231_lab.xml EX-101.LAB 679225
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cadx-20131231_pre.xml EX-101.PRE 551819
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33103 | Film No.: 14655578
SIC: 2834 Pharmaceutical Preparations